Hematology/Oncology Fellowship Program

(202) 444-7136



Letter from the Program Director

Thank you for your interest in the fellowship training program in Hematology/Medical Oncology at Georgetown University Medical Center and the Lombardi Cancer Center.  We are proud of our fellowship program, and the current and past fellows who have trained here.

This is an exciting time in the worlds of hematology and medical oncology, as the “War on Cancer” has started to bear fruit.  The knowledge about the mechanisms that underlie the development and progression of malignant processes has led to new therapies that have started to revolutionize the treatment of cancer.  At the Lombardi Comprehensive Cancer Center, active research is ongoing in all aspects of the study of cancer and its treatment, from basic research to new drug development to clinical trials, as well as the translational studies that help us understand the linkages between “the bench and bedside.”  Our fellows have the opportunity to participate in all phases of this research. Our expectation is that the tools that fellows learn and hone during their training will serve them throughout their careers in patient care, or research.

Georgetown’s Lombardi Comprehensive Cancer Center is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, and is widely recognized for both research and clinical excellence, with national leaders in many fields in both medical oncology and hematology.  The entire range of human cancers is treated at the Lombardi Comprehensive Cancer Center.  Thus, fellows may experience and interact with specialists in pediatric oncology, radiation oncology, and gynecologic oncology.  Moreover, patients and their cases are evaluated in multidisciplinary conferences in most oncologic disease types with surgeons, radiation oncologists, pathologists, and radiologists, allowing fellows to understand the entire range of treatments.

Our fellows flourish in an atmosphere of excellence in both clinical care and cutting edge clinical and basic research.  Fellows spend about half of their clinical time during fellowships in a disease-specific clinic setting, and are expected to present frequently on topics of interest.  In this setting, with an understanding of the mechanisms that underlie cancer development and drug activity, fellows acquire a solid foundation for patient care as well as for the integration of future developments in patient care.  The graduates of our program have entered all areas of hematology and medical oncology.  About half of our fellows enter private practice, and half pursue an academic career.  Some graduates have also entered government or industry.  The division has also developed the career of some of its fellows by appointment to the Georgetown faculty.  Six of our current faculty members graduated from our fellowship program.

As faculty members, my colleagues and I continue to be excited by what our training and educational programs offer us, our patients, and our fellows.  We hope you will join us.

Jimmy J. Hwang, MD
Assistant Professor of Medicine
Hematology/Medical Oncology Fellowship Program Director